Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products
October 1, 2025
FDA Practice Group Leader David Rosen is speaking in SAAMnow’s Fall Workshop in the session “Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products” on October 1.
The workshop will focus on regulatory, scientific, and technical challenges surrounding the presence of N-nitrosamine impurities in active pharmaceutical ingredients (APIs) and drug products. Participants will explore cutting-edge methods, regulatory updates, and research developments regarding N-nitrosamines.
The workshop will address:
- U.S. Food and Drug Administration (FDA) perspective on N-Nitrosamine Impurities,
- International Generic and Biosimilar Medicines Association (IGBA) perspective on nitrosamine impurities, the worldwide challenges,
- ICH M7 risk assessment and control of N-nitrosamine impurities,
- Over-the counter (OTC) drug products and their challenges with N-nitrosamine impurities, and
- Prescription drug products and their challenges with N-Nitrosamine impurities.
People
Related Insights
February 20, 2026
Energy Current
NAPE 2026 – A New Era
Each year, the oil & gas industry gathers for the “North America Prospect Expo,” better known as NAPE. The conference began modestly in a…
February 20, 2026
When Trade Becomes National Security: What the Administration’s 2025 National Security Strategy Signals for Companies and Cross Border Business
The Trump Administration’s release of the 2025 National Security Strategy (the “2025 NSS”) reinforces what has already become evident through policy and enforcement trends: trade, supply chains, and economic leverage are no longer supporting elements of national security policy, but rather its central tools. The most recent National Security Strategy was issued by the Biden administration in 2022.
February 20, 2026
Blogs
GRATs as an Estate Planning Tool for High‑Net‑Worth Individuals
The Federal gift and estate tax exemption (also known as the “basic exclusion amount”) increased to $15,000,000 per individual for calendar year 2026. Taxpayers whose assets are subject to gift or estate tax despite the increased exclusion amount still have tax planning strategies to consider. A grantor retained annuity trust, or GRAT, allows individuals to implement an estate tax planning strategy even if they have already used their basic exclusion amount.